China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Stock
Equities
000999
CNE0000011K8
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
60.35 CNY | -0.45% | +0.63% | +21.36% |
Sales 2024 * | 27.56B 3.82B | Sales 2025 * | 31.23B 4.33B | Capitalization | 59.64B 8.26B |
---|---|---|---|---|---|
Net income 2024 * | 3.3B 457M | Net income 2025 * | 3.79B 525M | EV / Sales 2024 * | 2.02 x |
Net cash position 2024 * | 3.85B 534M | Net cash position 2025 * | 6.58B 911M | EV / Sales 2025 * | 1.7 x |
P/E ratio 2024 * |
17.8
x | P/E ratio 2025 * |
15.6
x | Employees | 20,318 |
Yield 2024 * |
3.05% | Yield 2025 * |
3.13% | Free-Float | 36.9% |
1 day | -0.45% | ||
1 week | +0.63% | ||
Current month | +0.63% | ||
1 month | +18.71% | ||
3 months | +3.52% | ||
6 months | +37.85% | ||
Current year | +21.36% |
Managers | Title | Age | Since |
---|---|---|---|
Hua Wei Qiu
CEO | Chief Executive Officer | 57 | 07-12-26 |
Zheng Liang
DFI | Director of Finance/CFO | 46 | 19-10-28 |
Ji Hong Zhang
CMP | Compliance Officer | 53 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Hui Zhou
BRD | Director/Board Member | 53 | 05-08-10 |
Jun Yong Liu
BRD | Director/Board Member | 54 | 18-04-22 |
Jing Wen Weng
BRD | Director/Board Member | 48 | 15-12-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.83% | 0 M€ | -12.95% | - | |
0.69% | 2 M€ | -14.14% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 60.35 | -0.45% | 6,225,810 |
24-05-06 | 60.62 | +1.08% | 7,625,602 |
24-04-30 | 59.97 | +1.32% | 5,926,000 |
End-of-day quote Shenzhen S.E., May 06, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.36% | 8.31B | |
+33.43% | 690B | |
+26.43% | 546B | |
-5.12% | 358B | |
+19.59% | 323B | |
+4.89% | 287B | |
+14.32% | 235B | |
+5.79% | 199B | |
-9.49% | 195B | |
+4.26% | 161B |
- Stock Market
- Equities
- 000999 Stock